Proton boron capture therapy (PBCT) induces cell death and mitophagy in a heterotopic glioblastoma model
Francesco Paolo Cammarata(Institute of Molecular Bioimaging and Physiology), G. Cuttone(Istituto Nazionale di Fisica Nucleare, Laboratori Nazionali del Sud), Massimo Libra(University of Catania), Lucia Salvatorelli(University of Catania), Giada Petringa(Istituto Nazionale di Fisica Nucleare, Laboratori Nazionali del Sud), Alessandro Stefano(Institute of Molecular Bioimaging and Physiology), Selene Richiusa(Institute of Molecular Bioimaging and Physiology), Nunzio Vicario(University of Catania), Fabrizio Scopelliti(Ospedale Cannizzaro), Luigi Minafra(Istituto Nazionale di Fisica Nucleare), Valentina Bravatà(Istituto Nazionale di Fisica Nucleare), Sebastiano Cosentino(Ospedale Cannizzaro), Gaetano Magro(University of Catania), Massimo Ippolito(Ospedale Cannizzaro), Simona D’Aprile(University of Catania), Marco Calvaruso(Istituto Nazionale di Fisica Nucleare), Giuseppe Broggi(University of Catania), G.A.P. Cirrone(Istituto Nazionale di Fisica Nucleare), Filippo Torrisi(University of Catania), Danilo Porro(Institute of Molecular Bioimaging and Physiology), Giusi Irma Forte(Institute of Molecular Bioimaging and Physiology), Pierangela Giustetto(University of Catania), Rosalba Parenti(University of Catania), G. Russo(Institute of Molecular Bioimaging and Physiology)
Cited by 24
Related Papers
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
|Frontiers in Pharmacology|2018|878
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508